Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06710821 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06710821 · ClinicalTrials.gov record · last posted 2024-11-29

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Name: Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors — clinical trial record (NCT06710821)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorYizhuo Zhang

Started2024-12-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated November 29, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

A prospective, single-center Ia/Ib clinical study divided into two parts, including Phase Ia Dose Exploration and Phase Phase Ib Extension Phase.

Trial Details

NCT Number	NCT06710821
Lead Sponsor	Yizhuo Zhang
Conditions	Solid Tumor Cancer
Enrollment	40 participants
Start Date	2024-12-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-29